Literature DB >> 21281994

A new immune-modulating diet enriched with whey-hydrolyzed peptide, fermented milk, and isomaltulose attenuates gut ischemia-reperfusion injury in mice.

Kentaro Nakamura1, Saori Ogawa, Kazuo Dairiki, Kazuhiko Fukatsu, Hajime Sasaki, Tetsuo Kaneko, Taketo Yamaji.   

Abstract

BACKGROUND & AIMS: Gut ischemia-reperfusion (I/R) is considered an important mechanism underlying multiple organ failure after severe surgical insults. We previously demonstrated an enteral diet enriched with whey-hydrolyzed peptide, fermented milk, and isomaltulose to have anti-inflammatory effects in a concanavalin A-induced hepatitis model. Here, we investigated whether the immune-modulating diet (IMD), could prevent systemic inflammation, thereby improving survival in a gut I/R model.
METHODS: Mice were randomized into control enteral diet (n = 58) or IMD (n = 56) for 2 weeks' feeding. In experiment 1, 39 mice underwent 45 min of gut ischemia, and were sacrificed at 3 h after reperfusion to collect blood samples. Plasma IL-6 and glucose levels were measured. In experiment 2, 75 mice underwent 60 min of ischemia, and their survival was observed until 48 h.
RESULTS: Plasma IL-6 and glucose levels of the IMD group were significantly lower than those of control mice. In association with these changes, the IMD improved survival rate at early time points (12 and 30 h) after gut I/R (p < 0.05, χ(2) test).
CONCLUSIONS: Nutritional management with the IMD may be useful for preventing systemic inflammatory response after gut I/R.
Copyright © 2011 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21281994     DOI: 10.1016/j.clnu.2011.01.002

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  7 in total

1.  Effects of a preoperative immune-modulating diet in patients with esophageal cancer: a prospective parallel group randomized study.

Authors:  Hiroyuki Kitagawa; Tsutomu Namikawa; Tomoaki Yatabe; Masaya Munekage; Fumiyasu Yamasaki; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  Langenbecks Arch Surg       Date:  2017-03-10       Impact factor: 3.445

Review 2.  Appropriate protein and specific amino acid delivery can improve patient outcome: fact or fantasy?

Authors:  Christy M Lawson; Keith R Miller; Vance L Smith; Stephen A McClave
Journal:  Curr Gastroenterol Rep       Date:  2011-08

3.  Whey Protein (Ma'aljobon) as a Complementary Therapy for Treatment of Attention-deficit/ Hyperactivity Disorder (ADHD): A Randomized Open-label Controlled Clinical Trial.

Authors:  Zeinab Mostajeran; Seyed Hamdollah Mosavat; Mostafa Najafi; Majid Emtiazy; Mohammad Hashem Hashempur
Journal:  Galen Med J       Date:  2020-08-27

4.  Whey peptide-based enteral diet attenuated elastase-induced emphysema with increase in short chain fatty acids in mice.

Authors:  Koichi Tomoda; Kaoru Kubo; Kazuo Dairiki; Taketo Yamaji; Yoshifumi Yamamoto; Yasue Nishii; Atsuhiro Nakamura; Masanori Yoshikawa; Kaoru Hamada; Hiroshi Kimura
Journal:  BMC Pulm Med       Date:  2015-06-10       Impact factor: 3.317

5.  Nutritional treatment with an immune-modulating enteral formula alleviates 5-fluorouracil-induced adverse effects in rats.

Authors:  Kentaro Nakamura; Hidekazu Tonouchi; Akina Sasayama; Taketo Yamaji; Kinya Ashida
Journal:  PLoS One       Date:  2019-11-26       Impact factor: 3.240

6.  An immune-modulating formula comprising whey peptides and fermented milk improves inflammation-related remote organ injuries in diet-induced acute pancreatitis in mice.

Authors:  Kentaro Nakamura; Kazuhiko Fukatsu; Akina Sasayama; Taketo Yamaji
Journal:  Biosci Microbiota Food Health       Date:  2017-08-25

7.  Regulation of Inflammation by Sucrose Isomer, Turanose, in Raw 264.7 Cells.

Authors:  Joo-Yeon Chung; Yoo-Sun Kim; Yuri Kim; Sang-Ho Yoo
Journal:  J Cancer Prev       Date:  2017-09-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.